This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

June 24–26, 2020
The Sheraton Boston Hotel,
Boston, MA

Connect with Key Stakeholders and Propel Curative Progress, Orphan Product Success and Patient Advocacy

CBI/EBD Group’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs.

* * * BOOK WITH TOTAL CONFIDENCE * * *

As the COVID-19 situation is changing daily, we want you to feel totally confident about booking onto our events.

  • If Informa needs to reschedule the event, we will simply roll over your booking to the new dates
  • If Informa is unable to run the event again in the next 12 months, you will be entitled to a full refund
  • If you have questions or concerns, please contact matt.hannon@informa.com | +1-339-298-2157

Highlighted Articles

Rare Disease Article Pack

We have made available a series of articles highlighting various topics in rare disease research and regulation, and some companies involved in innovative drug development.

Download the pack
Bruce L. Levine is a man you can thank for your future cell therapy

Catch up on Bruce L. Levine's research and outlook on cell and gene therapies, and the importance of partnerships in progressing the field.

Read the article

2019 KEYNOTE TOPICS INCLUDED:

Patient and Caregiver Perspectives
Explore New Developments in Cures, Community, Collaboration and the Care Continuum for Patients and Caregivers

Science Luminaries 
Advancements in Gene Therapy that Are Tearing Down Barriers to Discovery in Rare Disease

Regulatory and Policy Update Address
Legislative Updates and New Initiatives within the FDA’s Orphan Drug Program

Focus on Funding
The Impact of Disruptive Investors, Drivers of Value and Funding Models for Success

Technology Spotlight 
Artificial Intelligence (AI) and Advanced Data Analytics — Reshaping Complex Diagnostics and Decision-Making in Rare Disease Drug Development


Download the 2020 Preview

See all the latest updates for CBI/EBD Group’s 2020 Rare Disease Summit.

Connect with Key Decision-Makers at the Rare Disease Summit


Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about custom opportunities to reach a qualified audience, contact LifeSciencePartners@informaconnectls.com.